Radiopharm Theranostics Announces Resignation of CFO Phillip Hains and Appointment of Aaron Laurita

On May 1, 2026, Radiopharm Theranostics Limited announced several changes to its executive leadership and corporate secretarial team, effective immediately. The company reported the resignation of Mr. Phillip Hains from his positions as Chief Financial Officer and Joint Company Secretary. Radiopharm will continue its service agreement with Acclime Australia for financial and administrative support. Under this arrangement, Mr. Aaron Laurita has been nominated to succeed Mr. Hains as the new Chief Financial Officer. Mr. Laurita is a Chartered Accountant with over a decade of experience in the biotechnology and commercial sectors across Australia, the U.S., and Canada. Additionally, Ms. Amritha Sushil has been appointed as Joint Company Secretary, joining Mr. Nathan Jong in the role. Ms. Sushil and Mr. Jong will serve as the primary points of contact for communications with the ASX. These administrative transitions are part of the company's ongoing engagement with Acclime Australia for statutory reporting and financial management services.